✦ LIBER ✦

Head injury, diagnostic X-rays, and risk of medulloblastoma and primitive neuroectodermal tumor: a Children’s Oncology Group study

✍ Scribed by Saira Khan; Alison A. Evans; Lucy Rorke-Adams; Manuela A. Orjuela; Tania Shiminski-Maher; Greta R. Bunin

Book ID: 106383045
Publisher: Springer Netherlands
Year: 2010
Tongue: English
Weight: 213 KB
Volume: 21
Category: Article
ISSN: 0957-5243
DOI: 10.1007/s10552-010-9529-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of Preradiotherapy Chem

A Phase II Study of Preradiotherapy Chemotherapy Followed by Hyperfractionated Radiotherapy for Newly Diagnosed High-Risk Medulloblastoma/Primitive Neuroectodermal Tumor: A Report From the Children's Oncology Group (CCG 9931)

✍ Jeffrey Allen; Bernadine Donahue; Minesh Mehta; Douglas C. Miller; Lucy B. Rorke 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 187 KB

A phase II study of the farnesyl transfe

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: A children's oncology group study

✍ Maryam Fouladi; H. Stacy Nicholson; Tianni Zhou; Fred Laningham; Kathleen J. Hel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## BACKGROUND. An open‐label Phase II study of tipifarnib was conducted to evaluate its safety and efficacy in children with recurrent or refractory medulloblastoma (MB)/primitive neuroectodermal tumor (PNET), high‐grade glioma (HGG), and diffuse intrinsic brainstem glioma (BSG). ## M